Lipika Goyal
Harvard University(US)Palo Alto University(US)Massachusetts General Hospital(US)Stanford Medicine(US)Center for Cancer Research(US)Stanford University(US)
Publications by Year
Research Areas
Fibroblast Growth Factor Research, Cholangiocarcinoma and Gallbladder Cancer Studies, Eosinophilic Disorders and Syndromes, Pancreatic and Hepatic Oncology Research, Cancer Genomics and Diagnostics
Most-Cited Works
- → AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma(2023)1,478 cited
- → Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study(2020)1,025 cited
- → Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology(2021)1,009 cited
- → Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer(2014)830 cited
- → Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma(2017)708 cited
- → New Horizons for Precision Medicine in Biliary Tract Cancers(2017)641 cited